Ikarian Capital »

Mbx Biosciences shares owned by Ikarian Capital

Quarter-by-quarter ownership of Mbx Biosciences (MBX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.8M 448k 17.50

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
Wellington Management Company
OrbiMed Advisors
NEA Management Company
Deep Track Capital
NVP Associates
EcoR1 Capital
Kynam Capital Management
BlackRock
Vanguard Group
Driehaus Capital Management
Franklin Resources
Cormorant Asset Management
Woodline Partners
Citadel Advisors

View all funds holding Mbx Biosciences